Evaluating molecular mechanism of hypotensive peptides interactions with renin and angiotensin converting enzyme

PLoS ONE

Volumn 9, Issue 3, 2014, Pages

  He, Rong ^a,b,c   Aluko, Rotimi E ^c   Ju, Xing Rong ^a,b  

^a NANJING UNIVERSITY OF FINANCE AND ECONOMICS   (China)

^b JIANGNAN UNIVERSITY   (China)

^c UNIVERSITY OF MANITOBA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; ARGINYLALANYLLEUCYLPROLINE; DIPEPTIDYL CARBOXYPEPTIDASE; PEPTIDE; RENIN; THREONYLPHENYLALANINE; TYROSYLLEUCINE; UNCLASSIFIED DRUG; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ALPHA HELIX; ARTICLE; BETA SHEET; BINDING AFFINITY; CIRCULAR DICHROISM; DRUG MECHANISM; DRUG PROTEIN BINDING; ENZYME ACTIVE SITE; ENZYME INHIBITION; HYDROGEN BOND; MOLECULAR DOCKING; PROTEIN CONFORMATION; ANIMAL; ANTAGONISTS AND INHIBITORS; BIOCATALYSIS; CHEMISTRY; DRUG EFFECTS; KINETICS; METABOLISM; PROTEIN SECONDARY STRUCTURE; SPECTROFLUOROMETRY; SPONTANEOUSLY HYPERTENSIVE RAT;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; ANTIHYPERTENSIVE AGENTS; BIOCATALYSIS; CATALYTIC DOMAIN; CIRCULAR DICHROISM; KINETICS; MOLECULAR DOCKING SIMULATION; PEPTIDES; PEPTIDYL-DIPEPTIDASE A; PROTEIN STRUCTURE, SECONDARY; RATS, INBRED SHR; RENIN; SPECTROMETRY, FLUORESCENCE;

EID: 84897421443     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0091051     Document Type: Article

References (28)

1. Daien V, Duny Y, Ribstein J, Du Cailar G, Mimran A, et al. (2012) Treatment of hypertension with renin-angiotensin system inhibitors and renal dysfunction: A systematic review and meta-analysis. Am J Hypertens 25: 126-132.
2. Connelly KA, Advani A, Advani S, Zhang Y, Thai K, et al. (2013) Combination angiotensin converting enzyme and direct renin inhibition in heart failure following experimental myocardial infarction. Cardiovasc Ther 31: 84-91.
3. Oliva RV, Bakris GL (2012) Combination therapy in hypertension treatment. In: Bakris G (ed) Managing the kidney when the heart is failing. New York: Springer. 59-72.
4. Sielecki AR, Hayakawa K, Fujinaga M, Murphy M, Fraser M, et al. (1989) Structure of recombinant human renin, a target for cardiovascular- active drugs, at 2.5 A resolution. Science 243: 1346-1351. (Pubitemid 19085370)
5. Bonanni L, Dalla Vestra M (2012) Oral renin inhibitors in clinical practice: a perspective review. Ther Adv Chronic Dis 3: 173-181.
6. Brew K (2003) Structure of human ACE gives new insights into inhibitor binding and design. Trends Pharmacol Sci 24: 391-394.
7. Valika AA, Gheorghiade M (2013) Ace inhibitor therapy for heart failure in patients with impaired renal function: a review of the literature. Heart Failure Rev 18: 135-140.
8. He R, Malomo SA, Alashi A, Girgih AT, Ju X, et al. (2013) Purification and hypotensive activity of rapeseed protein-derived renin and angiotensin converting enzyme inhibitory peptides. J Funct Foods 5: 781-789.
9. Girgih AT, Udenigwe CC, Li H, Adebiyi AP, Aluko RE (2011) Kinetics of enzyme inhibition and antihypertensive effects of hemp seed (Cannabis sativa L.) protein hydrolysates. J Am Oil Chem Soc 88: 1767-1774.
10. Li H, Aluko R E (2006) Structural modulation of calmodulin and calmodulin-dependent protein kinase II by pea protein hydrolysates. Int J Food Sci Nutr 57: 178-189. (Pubitemid 44822825)
11. Omoni AO, Aluko RE (2006) Effect of cationic flaxseed protein hydrolysate fractions on the in vitro structure and activity of calmodulin-dependent endothelial nitric oxide synthase. Mol Nutr Food Res 50: 958-966. (Pubitemid 44621800)
12. Whitmore L, Wallace BA (2008) Protein secondary structure analyses from circular dichroism spectroscopy: methods and reference databases. Biopolymers 89: 392-400.
13. Pan D, Cao J, Guo H, Zhao B (2012) Studies on purification and the molecular mechanism of a novel ACE inhibitory peptide from whey protein hydrolysate. Food Chem 130: 121-126.
14. Thangapandian S, John S, Sakkiah S, Lee KW (2011) Potential virtual lead identification in the discovery of renin inhibitors: Application of ligand and structure-based pharmacophore modeling approaches. Eur J Med Chem 46: 2469-2476.
15. Jao CL, Huang SL, Hsu KC (2012) Angiotensin I-converting enzyme inhibitory peptides: Inhibition mode, bioavailability, and antihypertensive effects. Bio- Medicine 2: 130-136.
16. Ko SC, Kang N, Kim EA, Kang MC, Lee SH, et al. (2012) A novel angiotensin I-converting enzyme (ACE) inhibitory peptide from a marine Chlorella ellipsoidea and its antihypertensive effect in spontaneously hypertensive rats. Process Biochem 47: 2005-2011.
17. Du L, Fang M, Wu H, Xie J, Wu Y, et al. (2013) A novel angiotensin Iconverting enzyme inhibitory peptide from Phascolosoma esculenta water-soluble protein hydrolysate. J Funct Foods 5: 475-483.
18. Katayama K, Tomatsu M, Kawahara S, Yamauchi K, Fuchu H, et al. (2004) Inhibitory profile of nonapeptide derived from porcine troponin C against angiotensin I2converting enzyme. J Agric Food Chem 52: 771-775.
19. Ahn CB, Jeon YJ, Kim YT, Je JY (2012) Angiotensin I converting enzyme (ACE) inhibitory peptides from salmon byproduct protein hydrolysate by Alcalase hydrolysis. Process Biochem, 47: 2240-2245.
20. Schmid FX (1989) Spectra methods of characterizing protein conformation and conformational changes. In: Creighton TE (ed) Protein structure: a practical approach. New York: Springer. 251-285.
21. Kobayashi Y, Yamauchi T, Katsuda T, Yamaji H, Katoh S (2008) Angiotensin-I converting enzyme (ACE) inhibitory mechanism of tripeptides containing aromatic residues. J Biosci Bioeng 106: 310-312.
22. Tanzadehpanah H, Asoodeh A, Saberi MR, Chamani J (2013) Identification of a novel angiotensin-I converting enzyme inhibitory peptide from ostrich egg white and studying its interactions with the enzyme. Innovative Food Sci Emerging Technol 18: 212-219.
23. Natesh R, Schwager SL, Sturrock ED, Acharya KR (2003) Crystal structure of the human angiotensin-converting enzyme-lisinopril complex. Nature, 421: 551-554. (Pubitemid 36168450)
24. Memarpoor-Yazdi M, Asoodeh A, Chamani J (2012) Structure and ACEinhibitory activity of peptides derived from hen egg white lysozyme. Int J Peptide Res Ther 18: 353-360.
25. Natesh R, Schwager SLU, Evans HR, Sturrock ED, Acharya KR (2004) Structural details on the binding of antihypertensive drugs captopril and enalaprilat to human testicular angiotensin I-converting enzyme. Biochem 43: 8718-8724. (Pubitemid 38880042)
26. Pina AS, Roque ACA (2009) Studies on the molecular recognition between bioactive peptides and angiotensin-converting enzyme. J Mol Recognition 22: 162-168.
27. Jimsheena V, Gowda LR (2010) Arachin derived peptides as selective angiotensin I-converting enzyme (ACE) inhibitors: structure-activity relationship. Peptides 31: 1165-1176.
28. Rahuel J, Rasetti V, Maibaum J, Rueger H, Goschke R, et al. (2000) Structure-based drug design: the discovery of novel nonpeptide orally active inhibitors of human renin. Chem Biol 7: 493-504. (Pubitemid 30466984)